Biotechnology/Chemical/Pharmaceutical Customer Partnership
Tuesday, March 15, 2005
United States Patent and Trademark Office
Madison Building, Auditorium North
600 Dulany Street, Alexandria, VA
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on December 8, 2004 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, March 15, 2005, from 9:00 am to 4:30 pm at Auditorium North in Madison Building, 600 Dulany Street, Alexandria, Virginia.
Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by March 10th, 2005.
|9:00-9:15||Greetings and Overview||Jasemine C. Chambers, Bruce Kisliuk, Directors, TC 1600|
|9:15-10:00||USPTO Goals Update||John Doll, Deputy Commissioner for Patent Resources and Planning|
|10:00-10:30||Incorporation by Reference in view of 37 CFR 1.57||Deborah Reynolds, Quality Assurance Specialist, TC1600|
|10:45-11:45||New Board Rules||Jeffrey Nase and Richard Torczon Administrative Patent Judges Board of Patent Appeals and Interferences|
|1:00-1:45||Post Grant Cancellations||James Toupin, General Counsel|
|1:45-2:45||New Matter Training Module||Rob Hill, Quality Assurance Specialist, Office of Patent Quality Assurance with Paula Hutzell, Practice Specialist TC1600|
|3:00-3:45||New Chemical Examples for Enablement Materials||Gary Kunz, Supervisory Patent Examiner, AU1616|
|3:45-4:00||Interview Practice||Cecilia Tsang, Supervisory Patent Examiner, AU1625|
|4:00-4:15||Closing Remarks/Discussion||Jasemine C. Chambers, Bruce Kisliuk, Directors, TC 1600|